Last CNY8.87 CNY
Change Today +0.08 / 0.91%
Volume 44.0M
600380 On Other Exchanges
As of 2:05 AM 03/2/15 All times are local (Market data is delayed by at least 15 minutes).

joincare pharmaceutical gr-a (600380) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/16/15 - CNY8.96
52 Week Low
06/25/14 - CNY4.85
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for JOINCARE PHARMACEUTICAL GR-A (600380)

Related News

No related news articles were found.

joincare pharmaceutical gr-a (600380) Related Businessweek News

No Related Businessweek News Found

joincare pharmaceutical gr-a (600380) Details

Joincare Pharmaceutical Group Industry Co., Ltd. manufactures and sells pharmaceutical products in China. It provides healthcare products under the Taitai, Jingxin, and Eagle brands; antibiotics and their intermediates comprising 7ACA, 4AA, and F9; and prescription drugs in the areas of digestive tract, blood vessel of heart and brain, infection, tumor, nervous cerebrovascular section, urinary system, etc. The company also offers over the counter medicines, such as Dele-Livzon, a gastrointestinal drug; Live Bifidobacterium preparations; Yiketie, an oral ulcer drugs; Antiviral Oral Granule, a cold medicine; external use skin medicine; compound dexamethasone acetate cream, etc. In addition, it provides Chinese traditional medicines, chemical formulations, detection reagents, health food products, oral solutions, fat eliminating capsules, oral band-aids, effervescent tablets, etc. Further, it offers troches, hard capsules, soft capsules, ointments, creams, gelatas, solutions, etc. The company also exports its products primarily to the United States, Australia, Singapore, Malaysia, Taiwan, Marco, and Hong Kong. Joincare Pharmaceutical Group Industry Co., Ltd. was founded in 1992 and is headquartered in Shenzhen, China.

Founded in 1992

joincare pharmaceutical gr-a (600380) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

joincare pharmaceutical gr-a (600380) Key Developments

Joincare Pharmaceutical Group Industry Co.,Ltd. Announces Management Changes

Joincare Pharmaceutical Group Industry Co. Ltd. announced that at its 5th Directorate Meeting, the directors approved the resignation of Qiu Qingfeng from position of General Manager and approved the appointment of Yang as Dongyun General Manager.

Joincare Pharmaceutical Group Industry Co.,Ltd., Board Meeting, Jan 05, 2015

Joincare Pharmaceutical Group Industry Co.,Ltd., Board Meeting, Jan 05, 2015. Agenda: To discuss and approve the proposal of writing off bad debts of Tiantong Securities Co., Ltd.; to consider the proposal of resignation of Qiu Qingfeng from position of general manager; and to consider the proposal of appointing Yang Dongyun general manager.

Joincare Pharmaceutical Group Industry Co.,Ltd. Reports Earnings Results for the First Three Quarters of 2014

Joincare Pharmaceutical Group Industry Co.,Ltd. reported earnings results for the first three quarters of 2014. For the period, the company reported basic earnings per share of CNY 0.1961 and weighted average return on net assets of 7.19%.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600380:CH CNY8.87 CNY +0.08

600380 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600380.
View Industry Companies

Industry Analysis


Industry Average

Valuation 600380 Industry Range
Price/Earnings 42.1x
Price/Sales 1.8x
Price/Book 3.1x
Price/Cash Flow 42.1x
TEV/Sales 0.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JOINCARE PHARMACEUTICAL GR-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at